Mikito Takefuji
- Cell Biology top 5%
-
- Cardiovascular Function and Risk Factors 4
- Cardiomyopathy and Myosin Studies 4
- Immunology and Allergy top 5%
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling 9
- Muscle Physiology and Disorders 4
-
- Protease and Inhibitor Mechanisms 4
-
- Adipose Tissue and Metabolism 5
-
- Peptidase Inhibition and Analysis 4
-
- Hormonal Regulation and Hypertension 4
Mikito Takefuji
45 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Cell Biology 390
- Cardiology and Cardiovascular Medicine 408
- Immunology and Allergy 97
- Molecular Biology 875
- Cancer Research 135
Countries citing papers authored by Mikito Takefuji
This map shows the geographic impact of Mikito Takefuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikito Takefuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikito Takefuji more than expected).
Fields of papers citing papers by Mikito Takefuji
This network shows the impact of papers produced by Mikito Takefuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikito Takefuji. The network helps show where Mikito Takefuji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikito Takefuji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 34 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 14 | |
| 11 | 2020 | 9 | |
| 12 | 2017 | 80 | |
| 13 | 2016 | 193 | |
| 14 | 2015 | 19 | |
| 15 | 2013 | 29 | |
| 16 | 2013 | 51 | |
| 17 | 2008 | 48 | |
| 18 | 2005 | 65 | |
| 19 | 2005 | 52 | |
| 20 | The Influence of Glycemic Control in Diabetic Patients on Neointimal Hyperplasia after Coronary Stent Implantation | 2003 | 1 |
About Mikito Takefuji
Mikito Takefuji is a scholar working on Cardiology and Cardiovascular Medicine, Behavioral Neuroscience and Cancer Research, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (9 papers), Adipose Tissue and Metabolism (5 papers), Muscle Physiology and Disorders (4 papers), Cardiovascular Function and Risk Factors (4 papers), Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers), Cardiomyopathy and Myosin Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Cell Biology (390 citations), Cardiology and Cardiovascular Medicine (408 citations) and Immunology and Allergy (97 citations). Mikito Takefuji has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Kozo Kaibuchi, Toyoaki Murohara, Nina Wettschureck, Stefan Offermanns, Takashi Watanabe, Shujie Wang, Tetsu Akiyama, Masato Nakagawa, Jun Noritake and Kazumasa Sato. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.